AGLE - Aeglea BioTherapeutics Inc
Close
12.01
0.970 8.077%
Share volume: 43,369
Last Updated: Mon 27 Nov 2023 10:00:00 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$11.04
0.97
8.79%
View ratios
Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | |
Report Date | 2022-05-05 | 2022-08-04 | 2022-11-03 | 2023-03-02 | 2023-05-11 | 2023-08-11 | 2023-11-09 | |
Total revenue | 1.362 M | 625.000 K | 174.000 K | 168.000 K | 198.000 K | 688.000 K | 0.000 | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 1.362 M | 625.000 K | 174.000 K | 168.000 K | 198.000 K | 688.000 K | 0.000 | |
-54.11% | -72.16% | -3.45% | 17.86% | 247.47% | -100.00% | |||
Operating expenses | 25.803 M | 23.048 M | 18.929 M | 19.330 M | 19.004 M | 29.448 M | 33.244 M | |
Selling general and admin | 8.825 M | 7.675 M | 6.952 M | 5.079 M | 5.228 M | 12.062 M | 8.584 M | |
Research and development | 16.978 M | 15.373 M | 11.977 M | 14.251 M | 13.776 M | 17.386 M | 24.660 M | |
Total expenses | 25.803 M | 23.048 M | 18.929 M | 19.330 M | 19.004 M | 159.934 M | 32.946 M | |
-10.68% | -17.87% | 2.12% | -1.69% | 741.58% | -79.40% | |||
Operating income | -24.441 M | -22.423 M | -18.755 M | -19.162 M | -18.806 M | -159.246 M | -32.946 M | |
Ebit | -24.441 M | -22.423 M | -18.755 M | -19.162 M | -18.806 M | -159.246 M | -32.946 M | |
Pretax income | -24.436 M | -22.314 M | -18.443 M | -18.758 M | -18.458 M | -217.074 M | -40.104 M | |
-8.68% | -17.35% | 1.71% | -1.60% | 1,076.04% | -81.53% | |||
Income tax | 0.000 | 9.000 K | -209.000 K | 64.000 K | -36.000 K | 7.000 K | 3.000 K | |
Net income basic | -24.436 M | -22.323 M | -18.234 M | -18.822 M | -18.422 M | -217.081 M | -40.107 M | |
8.65% | 18.32% | -3.22% | 2.13% | -1,078.38% | 81.52% | |||
Net income | -24.436 M | -22.323 M | -18.234 M | -18.822 M | -18.422 M | -217.081 M | -40.107 M | |
8.65% | 18.32% | -3.22% | 2.13% | -1,078.38% | 81.52% |